Bal Raj Bhandari

3.0k total citations
24 papers, 586 citations indexed

About

Bal Raj Bhandari is a scholar working on Epidemiology, Genetics and Gastroenterology. According to data from OpenAlex, Bal Raj Bhandari has authored 24 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Genetics and 8 papers in Gastroenterology. Recurrent topics in Bal Raj Bhandari's work include Inflammatory Bowel Disease (11 papers), Microscopic Colitis (10 papers) and Celiac Disease Research and Management (7 papers). Bal Raj Bhandari is often cited by papers focused on Inflammatory Bowel Disease (11 papers), Microscopic Colitis (10 papers) and Celiac Disease Research and Management (7 papers). Bal Raj Bhandari collaborates with scholars based in United States, Canada and Moldova. Bal Raj Bhandari's co-authors include William J. Sandborn, Brian G. Feagan, Elina Berliba, Marc Ferrante, Geert D’Haens, M. Durante, Jay Tuttle, Stuart Friedrich, Toshifumi Hibi∥ and Jochen Schmitz and has published in prestigious journals such as Gastroenterology, Alimentary Pharmacology & Therapeutics and Clinical Gastroenterology and Hepatology.

In The Last Decade

Bal Raj Bhandari

24 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bal Raj Bhandari United States	10	283	195	142	136	134	24	586
Mitsunori Noguchi Japan	13	170 0.6×	76 0.4×	190 1.3×	122 0.9×	206 1.5×	23	520
Lea I. Kredel Germany	8	221 0.8×	173 0.9×	185 1.3×	26 0.2×	100 0.7×	12	478
H Schmitt Germany	10	288 1.0×	150 0.8×	305 2.1×	19 0.1×	89 0.7×	49	640
Kumi Ishida Japan	11	90 0.3×	74 0.4×	68 0.5×	41 0.3×	134 1.0×	31	343
Andrea Fuhrer Switzerland	6	92 0.3×	52 0.3×	96 0.7×	21 0.2×	62 0.5×	11	433
K Marlicz Poland	15	99 0.3×	59 0.3×	105 0.7×	52 0.4×	374 2.8×	47	684
Ryan Murchie Canada	9	135 0.5×	50 0.3×	160 1.1×	18 0.1×	60 0.4×	11	411
Carolyn R. Weiss Canada	11	123 0.4×	76 0.4×	243 1.7×	10 0.1×	75 0.6×	15	504
Gilbert M. Wilcox United States	11	116 0.4×	141 0.7×	21 0.1×	63 0.5×	107 0.8×	16	519

Countries citing papers authored by Bal Raj Bhandari

Since Specialization

Citations

This map shows the geographic impact of Bal Raj Bhandari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bal Raj Bhandari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bal Raj Bhandari more than expected).

Fields of papers citing papers by Bal Raj Bhandari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bal Raj Bhandari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bal Raj Bhandari. The network helps show where Bal Raj Bhandari may publish in the future.

Co-authorship network of co-authors of Bal Raj Bhandari

This figure shows the co-authorship network connecting the top 25 collaborators of Bal Raj Bhandari. A scholar is included among the top collaborators of Bal Raj Bhandari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bal Raj Bhandari. Bal Raj Bhandari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McCallum, Richard W., et al.. (2023). Metoclopramide Nasal Spray in Women With Symptomatic Diabetic Gastroparesis: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study. Clinical Gastroenterology and Hepatology. 22(12). 2497–2505.e5. 8 indexed citations

Lawitz, Eric, Bal Raj Bhandari, Peter Ruane, et al.. (2022). Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat. Clinical Gastroenterology and Hepatology. 21(1). 143–152.e3. 34 indexed citations

Danese, Silvio, Barrett G. Levesque, Brian G. Feagan, et al.. (2022). Randomised clinical trial: a phase 1b study of GB004, an oral HIF‐1α stabiliser, for treatment of ulcerative colitis. Alimentary Pharmacology & Therapeutics. 55(4). 401–411. 26 indexed citations

Sandborn, William J., Robin Osterhout, Brian G. Feagan, et al.. (2021). DOP05 Target engagement and pharmacodynamic biomarker analysis following treatment with the oral gut-targeted HIF-1α stabilizer GB004 in a Phase 1b trial in Active Ulcerative Colitis. Journal of Crohn s and Colitis. 15(Supplement_1). S043–S043. 1 indexed citations

D’Haens, Geert, Toshifumi Hibi∥, Marc Ferrante, et al.. (2020). P687 Early and sustained improvement in stool frequency and rectal bleeding following 52 weeks of mirikizumab treatment. Journal of Crohn s and Colitis. 14(Supplement_1). S559–S560. 1 indexed citations

Sandborn, William J., Marc Ferrante, Bal Raj Bhandari, et al.. (2020). Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 20(1). 105–115.e14. 48 indexed citations

Sandborn, William J., Marc Ferrante, Bal Raj Bhandari, et al.. (2019). Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Ulcerative Colitis. Gastroenterology. 158(3). 537–549.e10. 179 indexed citations

D’Haens, Geert, William J. Sandborn, Marc Ferrante, et al.. (2019). 1004 – Maintenence Treatment with Mirikizumab, a P19-Directed Il-23 Antibody: 52-Week Results in Patients with Moderately-Toseverely Active Ulcerative Colitis. Gastroenterology. 156(6). S–216. 1 indexed citations

D’Haens, Geert, William J. Sandborn, Marc Ferrante, et al.. (2019). OP38 Maintenance treatment with mirikizumab, a p19-directed IL-23 antibody: 52-week results in patients with moderately-to-severely active ulcerative colitis. Journal of Crohn s and Colitis. 13(Supplement_1). S026–S027. 5 indexed citations

10.

Yang, Yunsheng, Jing‐Yuan Fang, Xiaozhong Guo, et al.. (2018). Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions. Journal of Gastroenterology and Hepatology. 33(5). 980–989. 39 indexed citations

11.

Curran, John, Hans Herfarth, Kiran Jagarlamudi, et al.. (2018). 85 - SER-287, an Investigational Microbiome Therapeutic, Induces Remission and Endoscopic Improvement in a Placebo-Controlled, Double-Blind Randomized Trial in Patients with Active Mild-to-Moderate Ulcerative Colitis. Gastroenterology. 154(6). S–25. 4 indexed citations

12.

Sandborn, William J., Bal Raj Bhandari, Charles Randall, et al.. (2018). Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease. Journal of Crohn s and Colitis. 12(9). 1021–1029. 44 indexed citations

13.

Sandborn, William J., Marc Ferrante, Bal Raj Bhandari, et al.. (2018). 882 - Efficacy and Safety of Anti-Interleukin-23 Therapy with Mirikizumab (LY3074828) in Patients with Moderate-To-Severe Ulcerative Colitis in a Phase 2 Study. Gastroenterology. 154(6). S–1360. 18 indexed citations

14.

McCallum, Richard W., et al.. (2017). Symptom Severity Influences Drug Efficacy in Women with Diabetic Gastroparesis: Results of a Phase 3 Study with Metoclopramide Nasal Spray. Gastroenterology. 152(5). S1313–S1313. 4 indexed citations

15.

Sandborn, William J., Bal Raj Bhandari, Ronald Fogel, et al.. (2016). Randomised clinical trial: a phase 1, dose‐ranging study of the anti‐matrix metalloproteinase‐9 monoclonal antibody GS‐5745 versus placebo for ulcerative colitis. Alimentary Pharmacology & Therapeutics. 44(2). 157–169. 50 indexed citations

16.

Sandborn, William J., Bal Raj Bhandari, Jane E. Onken, et al.. (2016). Tu1945 Clinical Response to Anti-MMP9 Antibody (GS-5745) is Accompanied by Histologic Improvement in Ulcerative Colitis. Gastroenterology. 150(4). S986–S986. 1 indexed citations

17.

McCallum, Richard W., Anthony Lembo, Tuba Esfandyari, et al.. (2013). Phase 2b, randomized, double‐blind 12‐week studies of TZP ‐102, a ghrelin receptor agonist for diabetic gastroparesis. Neurogastroenterology & Motility. 25(11). e705–17. 73 indexed citations

18.

Bhandari, Bal Raj, et al.. (1984). Merthiolate iodine formaldehyde test for detection of intestinal parasites.. PubMed. 21(10). 803–6. 1 indexed citations

19.

Bhandari, Bal Raj, et al.. (1973). Jonit in the treatment of hymenolepiasis: a new drug by cyclic regimen.. PubMed. 10(11). 675–7. 1 indexed citations

20.

Shrimali, R.K., et al.. (1971). Urinary retention due to pica ingestion in a child.. PubMed. 19(3). 285–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact